PolyPid : Investor Presentation (3e767d)

About this update from Polypid Ltd.

NASDAQ: PYPD Corporate Presentation August 2025 PolyPid Overview Polymer-Lipid Encapsulation matriX (PLEX) Platform granted and pending patents (1) Pre-NDA Lead Product D-PLEX in stage biopharma company Unique LOCAL Prolonged Delivery of APIs Phase 3 trial OncoPLEX Next Big Opportunity for Solid Tumors 100 employees (1) Global: Petach Tikva, Israel US: New Jersey NASDAQ: PYPD 3 1 As of August '25 Robust Pipeline with Multiple Near- and Longer-Term Inflection Points Attention : This is an excerpt of the original content. To continue reading it, access the original document here .

View stock analysis, news, and events for Polypid Ltd.